Role of long non-coding RNA NEAT1 in the prognosis of prostate cancer patients
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference29 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA,2018
2. Neoadjuvant and adjuvant treatment in high-risk prostate cancer;Bandini;Expert Rev Clin Pharmacol,2018
3. Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry;Francini;Prostate Cancer Prostatic Dis,2019
4. The role of genetic markers in the management of prostate cancer;Choudhury;Eur Urol,2012
5. Genomic markers in prostate cancer decision making;Cucchiara;Eur Urol,2018
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of lncRNA NEAT1 in human cancer chemoresistance;Cancer Cell International;2024-07-05
2. NEAT1 promotes the progression of prostate cancer by targeting the miR-582-5p/EZH2 regulatory axis;Cytotechnology;2024-02-14
3. The role of long noncoding RNAs in liquid–liquid phase separation;Cellular Signalling;2023-11
4. An updated review of contribution of long noncoding RNA-NEAT1 to the progression of human cancers;Pathology - Research and Practice;2023-05
5. Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer;Frontiers in Oncology;2023-03-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3